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‘If public health is to be more successful in the 21st century, it
must comprehend the magnitude of the forces against it and the
strategies used to engineer its defeat’ (McKinlay and Marceau,
2000b). Nowhere is this more apparent than the field of tobacco
control where the transnational tobacco industry’s enormous
wealth and political clout are fuelling a global public health
tragedy. Responsible for over 5 million premature deaths a year,
tobacco-related diseases are forecasted to kill over 10 million
people by 2020, 70% of these deaths occurring in low- and middle-
income countries (Tobacco Free Initiative, 2004). Based on current
trends, tobacco will kill 1 billion people in this century alone.
Despite these sobering statistics, tobacco use continues to be
promoted by a powerful industry, subsidised by governments, and
seen as a normal social activity by the public.
Some may argue that the tobacco epidemic’s insidiously slow
onset and ‘silence’ in comparison with dramatic outbreaks of
infectious diseases, such as AIDS and SARS, results in tobacco
control not being given sufficient priority, prestige, or resources
in public health planning and programmes. This may seem to be
an explanation for why many countries have not been able or
willing to take the necessary steps to control tobacco use, tobacco
control capacity is inadequate, and tobacco control programmes
are not adequately funded by either governments or international
aid agencies. However, this is only one of many reasons. Another
more important reason that explains the woefully inadequate
global response to the tobacco epidemic is directly related to the
aggressive activities of the transnational tobacco industry, which
values corporate profits over the unimaginable damage being
caused to the health and welfare of individuals and countries.
The tobacco industry’s past poor behaviour is well known.
However, recent industry initiatives aimed at remaking its
corporate image from pariah statues into a responsible corporate
citizen camouflages its continued efforts to resist restrictive
legislation that could lead to regulation and reduction in
consumption. The industry continues to attempt to realign
national and international laws so as to enlarge its corporate
rights and reduce its corporate responsibilities, and undermine
existing regulations.
TOBACCO INDUSTRY INVESTMENT
Tobacco is the only legal product that, when used as intended by
its manufactures, eventually kills half its users (Beaglehole and
Yach, 2003). In 2004, 75% of the world’s cigarette market was
controlled by just four companies: Philip Morris (PM), British
American Tobacco (BAT), Japan Tobacco (JT), and the China
National Tobacco Corporation. The latter’s share is attributed
almost entirely to its near monopoly over the enormous Chinese
market, but the others have been tireless in their pursuit of
worldwide sales. PM, BAT, and JT have combined tobacco sales of
over US$121 billion (World Bank, 2003).
It is not inconsequential that revenues generated by the
multinational tobacco companies dwarf the entire gross national
products (GNP) of some low- and middle-income countries. Using
their tremendous economic might, transnational tobacco compa-
nies have used trade liberalisation, foreign direct investment, and
marketing to take advantage of economically weak countries and
expand their global market. The transnational tobacco companies
have taken advantage of pressure on low- and middle-income
countries from the International Monetary Fund (IMF) and World
Bank to privatise state-owned industries and liberalise foreign
investment laws, as well as countries’ desperate need for foreign
exchange earnings. The industry penetration of formally nationa-
lised tobacco markets has had a dramatic impact on tobacco
prevalence and use. When questioned about the ethics of targeting
the world’s poor, a manager at Rothmans Export Ltd (part of BAT)
replied: ‘It would be stupid to ignore a growing market. I can’t
answer the moral dilemma. We are in the business of pleasing our
shareholders’ (Sweeney, 1988).
INDUSTRY LOBBYING
As a result of tobacco industry investment, governments view
tobacco production and sales as necessary for economic develop-
ment. Industry representatives also work hard to convince
governments that effective control measures will result in loss of
revenue from tobacco sales despite evidence that shows that
tobacco control policies tend to benefit the economy rather than to
cause harm (Jha and Chaloupka, 1999). The tobacco industry’s size
and wealth allows it to utilise many strategies and tactics to
promote its interests and also to interfere with public health and
tobacco control. A good deal of research has documented, at least
qualitatively, the tobacco industry’s specific actions to prevent or
undermine tobacco control programmes and organisations. Some
of these strategies and tactics include: (1) intimidation of
legislative bodies through political contributions, (2) the use of
lawsuit threats against whistle blowing media, (3) the use of front
groups, (4) reframing public debate from health to economic and
personal freedoms issues, (5) the obfuscation of science, (6)
peddling of influence, (7) use of voluntary codes and pre-emptive
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corruption (Saloojee and Dagli, 2000; Trochim et al, 2003). In 2002,
an expert committee convened by the World Health Organization
(WHO) found that tobacco companies had slowed and under-
mined effective tobacco control programmes around the world and
that the tobacco companies’ subversion of WHO’s activities had
resulted in ‘significant harm’ to global public health (World Health
Organization, 2000). Despite the negative attention, the industry
has not halted these type of activities and is now ramping up
efforts to circumvent the World Health Organization’s Framework
Convention on Tobacco Control (Framework Convention on
Tobacco Control, 2003).
CIRCUMVENTING POLICY
February 2005 marks a critical achievement to stem the global
tobacco epidemic, as 40 countries have ratified the WHO FCTC
and the treaty will go into effect. The WHO FCTC represents the
first time that low-, medium-, and high-income countries have
united to develop a collective response to reduce an epidemic of
chronic disease. The final WHO FCTC text commits Member States
to implementing proven tobacco control measures such as
increasing prices and taxes, imposing bans on advertising,
promotion, and sponsorship; disclosing tobacco product compo-
nents; requiring labelling standards and health warnings; promo-
ting public education and awareness campaigns; and conducting
research and surveillance programmes.
The WHO FCTC is in essence an attempt to develop a form of
health governance capable of effectively regulating transnational
corporations (Collin, 2002). However, there are already some
indications that tobacco companies are preparing to circumvent it.
In Africa, for example, we have seen the industry offer to paint
buildings in the colour of specific brands to circumvent the
restrictions on advertising. They are also increasingly point-of-
sales displays such as ‘Power Walls’ or ‘Tobacco Product Displays’
to advertise their products. They have been challenging graphic
warnings as infringements on trademark rights and are fighting to
reserve public areas for smoking through their courtesy of choice
campaigns and by pushing for the privatisation of public space.
CORPORATE SOCIAL RESPONSIBILITY
Regardless of these activities, the companies are working to
improve their public image through new Corporate Social
Responsibly (CSR) programmes. Through these programmes, the
transnational tobacco companies are acknowledging the scientific
literature on the health effects of active smoking and funding
youth prevention programmes in schools. They are also sponsor-
ing the arts, and supporting community programmes. There is
evidence that these programmes are working to improve their
image. By 2004, the stock value of Philip Morris/Altria completely
recovered from losses incurred as a result of past litigation and
stockholder distrust. In 2004, BAT was awarded the Stakeholder
Communication Award in the new PricewaterhouseCoopers
Building Public Trust Awards (Broughton, 2004). The industry’s
ability to remake its image while continuing to promote
aggressively a deadly product, resist new regulations and
circumvent existing laws continue to be challenges for future
tobacco control efforts.
CONCLUSION – TOBACCO CONTROL BEYOND THE
INDUSTRY
Despite industry efforts to undermine science and to inhibit the
implementation of effective regulation, a strong evidence base
regarding the health effects of active and passive smoking on
human health has been established, much progress has been made
in understanding which tobacco control strategies are effective
and the WHO FCTC serves as a global platform on which states
can develop comprehensive tobacco control programmes. How-
ever, changing a complex and addictive behavior, such as
smoking, is challenging even in the absence of a global industry
promoting it. New approaches and perspectives are needed. As
researcher John McKinley summarises, ‘The perspectives and
methods developed during the infectious and chronic disease eras
have limited utility in the face of newly emerging challenges to
public health’ (McKinlay and Marceau, 2000a). In regards to
tobacco, we now must adopt a more systems perspective, which
takes into consideration the social, cultural, economic, political,
and environmental factors that influence tobacco use including the
tremendous influence exerted by the transnational tobacco
industry on the behaviour of individuals as well as entire
countries. Such approaches to reduce tobacco use must be
comprehensive and investing in building country capacity to
deliver tobacco control as well as focusing efforts on developing
strong policies has proven to be effective in reducing tobacco use
(Stillman et al, 2003). There is a tremendous need to turn the
knowledge base that has been established over the last decades
into sustainable action. Such work will demand a renewed focus
on resource mobilisation at national and international levels as
well as effective cooperation, collaboration, and coordination
between tobacco control stakeholders in order to maximise the
scarce resources available (Stillman et al, in press). It is crucial
that the international tobacco control community now refocus its
efforts to ensure that individual countries have the knowledge,
tools, data, people, and organisations needed to implement the
FCTC and counter the activities of the transnational tobacco
industry (Wipfli et al, 2004).
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